Effectiveness of Low-intensity Laser on Pain in Patients With Supraspinatus Tendinopathy.
1 other identifier
interventional
40
1 country
1
Brief Summary
Tendinopathy is an inflammatory process that occurs in and around the tendon when both are affected by a certain injury. In the case of the supraspinatus muscle it is one of the most frequent causes of shoulder pain. To test the efficacy of laser treatment in reducing shoulder pain caused by supraspinatus muscle tendinopathy. A randomized controlled clinical trial (RCT) was carried out in which a physiotherapy intervention was performed using therapeutic laser for three months, to observe the influence on the pain generated by supraspinatus muscle tendinopathy in the shoulder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 12, 2025
CompletedFirst Submitted
Initial submission to the registry
November 22, 2025
CompletedFirst Posted
Study publicly available on registry
December 3, 2025
CompletedMay 4, 2026
April 1, 2026
11 months
November 22, 2025
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
intensity of pain.
measured using the VAS scale, where 0 is the least possible pain and 10 is the greatest possible pain
3 months
Secondary Outcomes (2)
Range of motion
3 months
Patient quality of life
3 months
Study Arms (2)
Laser treatment
EXPERIMENTALLaser treatment on tendinophaty shoulder.
Placebo Group
PLACEBO COMPARATORPlacebo treatment on tendinophaty shoulder.
Interventions
A placebo treatment is carried out on the shoulder, simulating the application of the laser.
Eligibility Criteria
You may qualify if:
- Score of 3 or higher on the VAS scale for the shoulder.
- Adequate cognitive ability for comprehension.
- Rotator cuff tendinopathy confirmed by ultrasound at the study center, either due to tendon inflammation, presence of hypoechoic areas, calcification, fibrillar disorganization, and/or neovascularization in the supraspinatus muscle.
- Pain in the proximal lateral part of the arm that worsens with abduction.
You may not qualify if:
- Contraindications specific to laser treatment (e.g., tumors, presence of pacemaker or defibrillator, pregnancy, etc.).
- History of glenohumeral fracture and rheumatoid arthritis.
- Rheumatic, neurological, or structural polymyalgia affecting the joint.
- Previous surgeries.
- Pregnant or breastfeeding women.
- Taking anticoagulants or antiplatelet agents.
- Diabetes mellitus.
- Cardiac dysfunction.
- Infiltrative and/or rehabilitative treatment in the two months prior to recruitment.
- Pre-existing conditions associated with pain in the upper extremities. Difficulties with follow-up.
- Depression.
- Treatment with another intervention; during the study, they will not be able to undergo it.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Pontificia de Salamanca
Salamanca, 37002, Spain
Related Publications (5)
Redondo-Alonso L, Chamorro-Moriana G, Jimenez-Rejano JJ, Lopez-Tarrida P, Ridao-Fernandez C. Relationship between chronic pathologies of the supraspinatus tendon and the long head of the biceps tendon: systematic review. BMC Musculoskelet Disord. 2014 Nov 18;15:377. doi: 10.1186/1471-2474-15-377.
PMID: 25408141RESULTHaik MN, Alburquerque-Sendin F, Moreira RF, Pires ED, Camargo PR. Effectiveness of physical therapy treatment of clearly defined subacromial pain: a systematic review of randomised controlled trials. Br J Sports Med. 2016 Sep;50(18):1124-34. doi: 10.1136/bjsports-2015-095771. Epub 2016 Jun 10.
PMID: 27288517RESULTRomero-Morales C, Bravo-Aguilar M, Abuin-Porras V, Almazan-Polo J, Calvo-Lobo C, Martinez-Jimenez EM, Lopez-Lopez D, Navarro-Flores E. Current advances and novel research on minimal invasive techniques for musculoskeletal disorders. Dis Mon. 2021 Oct;67(10):101210. doi: 10.1016/j.disamonth.2021.101210. Epub 2021 Jun 4.
PMID: 34099238RESULTAsensio-Olea L, Leiros-Rodriguez R, Marques-Sanchez MP, de Carvalho FO, Maciel LYS. Efficacy of percutaneous electrolysis for the treatment of tendinopathies: A systematic review and meta-analysis. Clin Rehabil. 2023 Jun;37(6):747-759. doi: 10.1177/02692155221144272. Epub 2022 Dec 30.
PMID: 36583575RESULTSanchez-Sanchez JL, Calderon-Diez L, Herrero-Turrion J, Mendez-Sanchez R, Arias-Buria JL, Fernandez-de-Las-Penas C. Changes in Gene Expression Associated with Collagen Regeneration and Remodeling of Extracellular Matrix after Percutaneous Electrolysis on Collagenase-Induced Achilles Tendinopathy in an Experimental Animal Model: A Pilot Study. J Clin Med. 2020 Oct 15;9(10):3316. doi: 10.3390/jcm9103316.
PMID: 33076550RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- triple blinding
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 22, 2025
First Posted
December 3, 2025
Study Start
September 12, 2023
Primary Completion
July 24, 2024
Study Completion
June 12, 2025
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Currently and for 12 months.
- Access Criteria
- Upon request to the corresponding author.
De-identified individual participant data, including the data dictionary, will be shared with qualified researchers. The shared IPD will include the data needed to reproduce the study findings, such as the de-identified participant-level data underlying the results reported in the publication.